Androgen suppression with dose-escalated radiotherapy does not improve overall survival
In the NRG Oncology clinical trial NRG-RTOG 0815 comparing dose escalated radiotherapy (RT) in combination with short-term androgen suppression (ADT) to dose escalated RT alone for intermediate-risk prostate cancer patients, ...
Oct 26, 2021
0
2